99 related articles for article (PubMed ID: 33886687)
1. The impact of cytochrome P450 3A genetic polymorphisms on tacrolimus pharmacokinetics in ulcerative colitis patients.
Furuse M; Hosomi S; Nishida Y; Itani S; Nadatani Y; Fukunaga S; Otani K; Tanaka F; Nagami Y; Taira K; Kamata N; Watanabe T; Watanabe K; Fujiwara Y
PLoS One; 2021; 16(4):e0250597. PubMed ID: 33886687
[TBL] [Abstract][Full Text] [Related]
2. Association of CYP3A4-392A/G, CYP3A5-6986A/G, and ABCB1-3435C/T Polymorphisms with Tacrolimus Dose, Serum Concentration, and Biochemical Parameters in Mexican Patients with Kidney Transplant.
Alatorre-Moreno EV; Saldaña-Cruz AM; Pérez-Guerrero EE; Morán-Moguel MC; Contreras-Haro B; López-de La Mora DA; Dávalos-Rodríguez IP; Marín-Medina A; Rivera-Cameras A; Balderas-Peña LA; Gómez-Ramos JJ; Cortés-Sanabria L; Salazar-Páramo M
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674430
[TBL] [Abstract][Full Text] [Related]
3. Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio.
Vidal-Alabró A; Colom H; Fontova P; Cerezo G; Melilli E; Montero N; Coloma A; Manonelles A; Favà A; Cruzado JM; Torras J; Grinyó JM; Lloberas N
Nefrologia (Engl Ed); 2024; 44(2):204-216. PubMed ID: 38614890
[TBL] [Abstract][Full Text] [Related]
4. Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers.
Chen YR; Yu X; Xu LM; Mei J; Tian ML; Xu M; Jin QY; Ye LB; Yang SX
Xenobiotica; 2024 Jan; 54(1):38-44. PubMed ID: 38085693
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interactions between tacrolimus and Wuzhi capsule in liver transplant recipients: Genetic polymorphisms affect the drug interaction.
Huang S; Song W; Jiang S; Li Y; Wang M; Yang N; Zhu H
Chem Biol Interact; 2024 Mar; 391():110906. PubMed ID: 38340974
[TBL] [Abstract][Full Text] [Related]
6. Single Nucleotide Polymorphisms of CYP3A4 and CYP3A5 in Romanian Kidney Transplant Recipients: Effect on Tacrolimus Pharmacokinetics in a Single-Center Experience.
Rotarescu CA; Maruntelu I; Rotarescu I; Constantinescu AE; Constantinescu I
J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610733
[No Abstract] [Full Text] [Related]
7. Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.
Puranik YG; Birnbaum AK; Marino SE; Ahmed G; Cloyd JC; Remmel RP; Leppik IE; Lamba JK
Pharmacogenomics; 2013 Jan; 14(1):35-45. PubMed ID: 23252947
[TBL] [Abstract][Full Text] [Related]
8. Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function.
Fohner AE; Dalton R; Skagen K; Jackson K; Claw KG; Hopkins SE; Robinson R; Khan BA; Prasad B; Schuetz EG; Nickerson DA; Thornton TA; Dillard DA; Boyer BB; Thummel KE; Woodahl EL
Clin Transl Sci; 2021 Jul; 14(4):1292-1302. PubMed ID: 33503331
[TBL] [Abstract][Full Text] [Related]
9. Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone.
Resál T; Mangó K; Bacsur P; Szántó K; Pigniczki D; Keresztes C; Rutka M; Bálint A; Milassin Á; Bor R; Fábián A; Szepes Z; Farkas K; Monostory K; Molnár T
Expert Opin Drug Saf; 2023; 22(6):517-524. PubMed ID: 36811412
[TBL] [Abstract][Full Text] [Related]
10. A Machine Learning-Based Identification of Genes Affecting the Pharmacokinetics of Tacrolimus Using the DMET
Gim JA; Kwon Y; Lee HA; Lee KR; Kim S; Choi Y; Kim YK; Lee H
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260456
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tacrolimus in older adults with ulcerative colitis: a retrospective study.
Ito A; Murasugi S; Omori T; Nakamura S; Tokushige K
BMC Gastroenterol; 2024 Jan; 24(1):22. PubMed ID: 38191328
[TBL] [Abstract][Full Text] [Related]
12. Association between CYP3A4/CYP3A5 genetic polymorphisms and treatment outcomes of atorvastatin worldwide: is there enough research on the Egyptian population?
Maslub MG; Radwan MA; Daud NAA; Sha'aban A
Eur J Med Res; 2023 Sep; 28(1):381. PubMed ID: 37759317
[TBL] [Abstract][Full Text] [Related]
13. Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China.
Jia X; Zhang X; Zhou T; Sun D; Li R; Yang N; Luo Z
PLoS One; 2023; 18(12):e0295184. PubMed ID: 38117809
[TBL] [Abstract][Full Text] [Related]
14. The Impact of
Choong CL; Islahudin F; Wong HS; Yahya R; Mohd Tahir NA; Makmor-Bakry M
J Pers Med; 2024 Apr; 14(4):. PubMed ID: 38673067
[TBL] [Abstract][Full Text] [Related]
15. Research progress regarding
Jia Q; Ding Q; Shao K; Dang J; Zhang F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1874-1881. PubMed ID: 38448381
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 3A4 activity and genetic variants as predictors of liver failure in patients with obstructive jaundice.
Lebedev SS; Tavobilov MM; Karpov AA; Abramov KA; Bochkov PO; Shevchenko RV; Denisenko NP; Shabunin AV; Sychev DA
Free Radic Biol Med; 2023 Nov; 208():229-235. PubMed ID: 37573895
[TBL] [Abstract][Full Text] [Related]
17. Effects of CYP3A5*3 genetic polymorphisms on the pharmacokinetics of perampanel in Chinese pediatric patients with epilepsy.
Zhao T; Feng JR; Zhang HL; Yu J; Feng J; Sun KF; Yu LH; Sun Y; Li HJ
Pharmacogenet Genomics; 2024 May; ():. PubMed ID: 38728170
[TBL] [Abstract][Full Text] [Related]
18. Pilot Study: Personalized Medicine in Endoscopy, Can Pharmacogenomics Predict Response to Conscious Sedation?
Zaver HB; Ghoz H; Malviya B; Bali A; Antwi S; Moyer AM; Bi Y
J Pers Med; 2023 Jul; 13(7):. PubMed ID: 37511720
[TBL] [Abstract][Full Text] [Related]
19. Cancer occurrence following azathioprine treatment in myasthenia gravis patients: A systematic review and meta-analysis.
Zhang Z; Wang M; Xu L; Jiang B; Jin T; Shi T; Xu B
J Clin Neurosci; 2021 Jun; 88():70-74. PubMed ID: 33992207
[TBL] [Abstract][Full Text] [Related]
20. CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients.
Krall P; Yañez D; Rojo A; Delucchi Á; Córdova M; Morales J; Boza P; de la Rivera A; Espinoza N; Armijo N; Castañeda LE; Farfán MJ; Salas C
Front Pharmacol; 2021; 12():653525. PubMed ID: 33967795
[No Abstract] [Full Text] [Related]
[Next] [New Search]
